Skip to main content
. 2015 Jul 8;9(2):215–220. doi: 10.1159/000437138

Fig. 1.

Fig. 1

Clinical course. The patient improved after stopping treatment of simeprevir with PEG-IFN α-2a plus ribavirin. y = Years; w = weeks; LIU/mL = log IU/ml; Neg = negative.